title: [Regulated hypothermia after cardiac arrest. A glimpse into the future].
abstract: The introduction of therapeutic mild hypothermia after cardiac arrest allows the neuronal damage caused by global cerebral ischemia to be advantageously influenced for the first time. Currently, hypothermia is induced by external or internal cooling of the patient (forced hypothermia). However, this results in activation of counter-regulation mechanisms which could be possible risk factors for the patient. The aim of this article is to give a review of possible, but at present only experimental, methods which could allow the body temperature set point to be decreased pharmacologically (regulated hypothermia). Various classes of substances will be discussed based on their effect on thermoregulation and their performance in animal experiments on cerebral ischemia.
authors.affiliation: Klinik für Anaesthesiologie, Universitätsklinikum, Im Neuenheimer Feld 110, 69120 Heidelberg.
authors.forename: A
authors.initials: A
authors.lastname: Schneider
authors.forename: E
authors.initials: E
authors.lastname: Popp
authors.forename: B W
authors.initials: BW
authors.lastname: Böttiger
mesh_terms: D017371:8-Hydroxy-2-(di-n-propylamino)tetralin / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001831:Body Temperature / Q000187:drug effects / Q000502:physiology; D001833:Body Temperature Regulation / Q000187:drug effects / Q000502:physiology; D002545:Brain Ischemia / Q000209:etiology / Q000628:therapy; D016308:Enkephalin, Leucine-2-Alanine / Q000494:pharmacology / Q000627:therapeutic use; D006323:Heart Arrest / Q000150:complications / Q000628:therapy*; D006801:Humans; D007036:Hypothermia, Induced / Q000009:adverse effects; D009496:Neurotensin / Q000494:pharmacology / Q000627:therapeutic use; D012307:Risk Factors; D017366:Serotonin Receptor Agonists / Q000494:pharmacology / Q000627:therapeutic use
chemical_list: D017366:Serotonin Receptor Agonists; D009496:Neurotensin; D016308:Enkephalin, Leucine-2-Alanine; D017371:8-Hydroxy-2-(di-n-propylamino)tetralin